Biomerica, Inc.
- BMRA
- NASDAQ
- Medical devices
- Diagnostic Assays/Kits
- Therapeutic Solutions
$1.76
Today −4.86%Quote Oct 19, 2026, 08:00 PM UTC
−21.61%over the last month
Max drawdown −35.3%From 1-month high −33.5%3 months +15.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Biomerica
Biomerica, Inc. is a biomedical technology firm that invents, secures intellectual property for, produces, and globally distributes diagnostic and therapeutic solutions aimed at identifying and addressing a range of medical conditions and diseases. The company's diagnostic testing kits analyze patient samples, such as blood, urine, or stool, to pinpoint various illnesses and health complications.
Where the money comes from
Q3 2024 revenue $688,000
- Clinical Lab$404,00058.7%
- Contract Manufacturing$281,00040.8%
Sector
Healthcare
Industry
Medical devices
Exchange
NASDAQ
Employees
50
Market value
$8.1M
Quote Oct 19
Floor
$1.73
1.7% below price
Resistance
$1.96
11.2% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BMRAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free